Company page

Moderna, Inc.

Moderna, Inc. is a public company traded under the ticker MRNA in the American market. The company has a market capitalization of approximately $24.53 billion. Moderna is known for its innovative work in biotechnology, particularly in the development of mRNA-based therapeutics and vaccines.

MRNA:NASDAQUpdated July 21, 2026
Moderna, Inc. logo
Ticker
MRNA:NASDAQ
Asset type
Stock
Market cap
$24.53B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD